Author Interviews, COVID -19 Coronavirus, Vaccine Studies / 02.08.2022

MedicalResearch.com Interview with: Dr Emma Wall Senior Clinical Research Fellow, UCLH-Crick Legacy study Consultant Infectious Diseases UCLH MedicalResearch.com:  What is the background for this study?  Response: Since April 2022, both the UK and US have changed their COVID-19 isolation and testing policies. The impact these changes in the guidance and vaccination on community-acquired COVID-19 caused by recent SARS-CoV-2 variants of concern (VOC) has not been fully tested, including infections with BA.2. We aimed to characterise both symptoms and viral loads over the course of COVID-19 infection in otherwise-healthy, vaccinated, non-hospitalised adults, to assess whether current guidance remains justified. All participants were included in the UCLH-Crick Legacy study, a prospective, observational cohort study of otherwise healthy adults who have been taking part in regular workplace testing for SARS-CoV-2 in London We sent swabs by same-day courier every other day to all adults who reported a positive PCR or lateral flow test to the study team up to day 10 after the start of each infection. We confirmed which variant caused the infection by PCR and sequencing. All participants completed linked symptom diaries. We compared symptoms and changes in the amount of virus detected in the nose and throat during infection between study participants reporting COVID-19 caused by VOCs Delta and Omicron BA.1 and BA.2. We then analysed how many of our participants would meet current UK/US isolation guidelines. (more…)
Author Interviews, COVID -19 Coronavirus, Vaccine Studies / 02.09.2021

MedicalResearch.com Interview with: David H. Canaday, MD Associate Director of Research Geriatric Research, Education and Clinical Center (GRECC),  Cleveland VA Professor, Division of Infectious Disease, Case Western Reserve University Cleveland, Ohio MedicalResearch.com: What is the background for this study? Response: We were interested in following up on a prior study where we determined that nursing home residents, and in particular those that were given the Pfizer shot who never had COVID-19 in the past, had 4 fold less antibodies against the key Spike protein of the coronavirus than did the group of health care workers who were the other group studied. We wanted to see how those antibodies levels in these groups held up over 6 months.  (more…)